Home > ISAAR > Past ISAARs


September 14-16
BEXCO, Busan, Korea

Keynote Lectures & Plenary keynote lectures
Category Date Title Speaker
Keynote Lectures 1
Are we facing post-antibiotic era?
September 14
Antibiotic Stewardship: The Way Forward or Back to the Future? Walter Wilson
Global antimicrobial resistance: what'll emerge next? David Livermore
Global and regional impact of antimicrobial resistance: A tragedy of the commons Jae-Hoon Song
Global issues for combating antimicrobial resistance Keiji Fukuda
Keynote Lectures 2
Combating emerging infectious diseases: today and tomorrow
September 14
Deadliest Enemy: Our War Against Killer Germs Michael Osterholm
The Evolving Global Outbreak Alert and Response Network (GOARN 2.0) Dale Fisher
Plenary Lecture 1 September 15
Telehealth: new and important ways to treat infections Franklin Cockerill
Plenary Lecture 2 September 15
Vaccines against emerging infections: where are we? Jerome Kim
Plenary Lecture 3 September 16
Infection prevention and control: what's new? Stephan Harbarth
Plenary Lecture 4 September 16
Rapid diagnostics for infectious diseases: a solution to combat antimicrobial resistance Robin Patel
Plenary Lecture 5 September 16
Tissue injury pathophysiology of severe sepsis Jaroslaw Zmijewski
Session Topic Speaker
September 15 (09:00-11:00)
Session 1
Community-associated MRSA infections
Unique Evolution of CA-MRSA Clones Geoffrey Coombs
CA-MRSA as a new nosocomial pathogen Doo-Ryeon Chung
A vaccine for Staphylococcus aureus? Robert Daum
Treatment options for CA-MRSA infections Ian Gould
Session 2
Emerging viral infections and vaccines
Recent highly pathogenic avian influenza outbreaks by H5N6 and H5N8 viruses and molecular risk assessment of mammalian pathogenicity Hyuk-Joon Kwon
Virological and immunological responses in MERS patients Nam-Hyuk Cho
Clinical, epidemiological, and virological aspects of SFTS in Japan: what we have learned and what we should do? Masayuki Saijo
Infectious Diseases in the 21st Century: A Battle Plan for Survival Michael Osterholm
Session 3
Colistin-resistant gram-negatives
Colistin resistance in gram-negatives Po-Ren Hsueh
Emergence of mcr-1 colistin resistance: a new story begins Eun-Jeong Yoon
What to use in the clinical practice? Yohei Doi
Colistin resistance: is it preventable? Anucha Apisarnthanarak
September 15 (16:00-17:30)
Session 4
Carbapenem-resistant Enterobacteriaceae
Carbapenemases, from KPC to NDM to OXA-48: diverse enzymes in diverse clones David Livermore
Diagnostic challenges in detecting carbapenem resistance Kyungwon Lee
Antimicrobial treatment; recommendation and options for carbapenem-resistant Enterobacteriaceae Ami Neuberger
Session 5
One world, one health
One Health lessons from investigation emerging viruses of bat origin Linfa Wang
One health approaches to zoonotic diseases and AMR Yong Ho Park
One health activities on Nipah in Bangladesh: a high risk country for zoonotic disease spillover to man John Clemens
Session 6
Pediatric mycoplasmal infections
Mycoplasma pneumoniae Infection in Children Cheng-Hsun Chiu
Macrolide-resistant Mycoplasma pneumoniae pneumonia in children Eun Hwa Choi
Management of severe mycoplasma infection: role of antibiotics and steroid Nancy Henry
Session Topic Speaker
September 16 (09:00-11:00)
Session 7
Current controversies in infection control
Knowledge gaps in hand hygiene monitoring and efficacy Stephan Harbarth
Fight against healthcare-borne flavivirus named HCV Eun Ju Choo
Active surveillance based on MDR gram-negative pathogens? Anucha Apisarnthanarak
Ten-year experience of KONIS Young Hwa Choi
Session 8
Current controversies in fungal infections
Diagnosis of fungal infections: current status Jong Hee Shin
The newest treatment strategies for candidemia Thomas Patterson
Epidemiology and approach to management to invasive aspergillosis and mucormycosis Sharon Chen
Endemic fungal infection in the Asia-Pacific region (in the context of altered immunity) Louis Chai
Session 9
Current controversies in HIV infection
Pre-exposure prophylaxis: from science to implementation Rossana Ditangco
Broadly neutralizing antibody for treatment and prevention of HIV infection Shuzo Matsushita
Genome editing using programmable nucleases including CRISPR-Cas Hyongbum Kim
Achievability of HIV treatment as prevention Shui Shan Lee
September 16 (16:00-17:30)
Session 10
Molecular diagnostics for infectious diseases
Epidemiology of extensively-resistant Gram-negative in Mainland China Hui Wang
Improving the diagnosis and management of serious infection using rapid point-of-care metagenomic sequencing Justin O'Grady
NGS for infectious disease diagnosis and surveillance Robin Patel
Session 11
Management of sepsis
Protein synthesis enzymes as primary defense system against infection Sunghoon Kim
Resuscitation in sepsis: reexamining the paradigm Jung-Hyun Choi
New therapeutic targets for sepsis: better late than never Jaroslaw Zmijewski
Session 12
Antimicrobial stewardship program
The role of behavioural sciences in antibiotic stewardship Victor Lim
Impact of ASP program on reducing AMR in the hospitals David Lye
Computer decision support and surveillance systems for ASP Jacob Lee
޴ٷΰ ΰ